fintech / news / / Bnn Bloomberg
Apotex expects to sell between 41.7 million and 50 million shares at a price between $20 and $24 per share.
Apotex Health Corp. plans to raise about $1 billion through an initial public offering.
KEY POINTS
- Between 35.4 million and 42.5 million shares will be sold in a treasury offering worth $850 million.
- A secondary offering will include 6.25 million to 7.5 million shares from existing shareholders, totaling $150 million.
- Selling shareholders may grant underwriters an over-allotment option for up to 7.5 million extra shares.
COMPANIES
Summarized by Newsio from Bnn Bloomberg. How we summarize →